UCB’s DZP moving into Phase III trials despite Phase II failure

The Phase III study, which will be randomised, double-blind and placebo-controlled, will enroll approximately 450 participants suffering from SLE. Credit: Jarun Ontakrai / Shutterstock.



  • dzp sle